Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS)
Clinical trial NCT06111586 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06111586
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-11
- Primary completion
- 2027-04-28
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.